(Q46036049)

18 December 2017

title

Effects of extended-release guanfacine on ADHD symptoms and sedation-related adverse events in children with ADHD. (English)

1 reference

18 December 2017

author

Stephen Faraone

series ordinal

1

1 reference

18 December 2017

Stephen J Glatt

series ordinal

2

1 reference

18 December 2017

publication date

24 April 2009

1 reference

18 December 2017

Journal of Attention Disorders

published in

1 reference

18 December 2017

volume

13

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

532-538

1 reference

18 December 2017

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332472

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332472

Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332472

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332472

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332472

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332472

21 January 2018

Identifiers

DOI

10.1177/1087054709332472

1 reference

18 December 2017

PubMed ID

19395648

1 reference

18 December 2017